Cysteine-Labeled Protein Probes for Unbound Analyte Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for designing protein probes to measure unbound analytes, such as free fatty acids, are inefficient due to the lack of specificity and sensitivity, requiring extensive experimentation and resulting in probes with inconsistent labeling and reduced sensitivity, making it difficult to accurately determine unbound concentrations.
Innovation Solution
A high-throughput method for generating and screening cysteine-labeled protein probes, involving mutagenesis, purification, and labeling with specific fluorophores to achieve consistent and sensitive fluorescence ratio changes upon analyte binding, allowing for rapid identification of probes with desired specificities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional protein probe design methods are used, then extensive experimentation is required, but this results in inconsistent labeling and reduced sensitivity
Solution Approach 1:
The patent introduces cysteine mutations at specific positions in the protein sequence to create unique labeling sites. By changing the amino acid parameters (introducing cysteine residues with thiol groups), the patent achieves site-specific fluorescent labeling that is consistent and reproducible, eliminating the need for extensive trial-and-error experimentation. The cysteine residues provide chemically distinct labeling opportunities compared to traditional methods.
2Measurement precision
If cysteine-labeled probes are developed, then specificity and sensitivity are improved, but the complexity of probe generation increases
Solution Approach 1:
The patent segments the protein structure by introducing specific cysteine mutations at defined positions (e.g., position 27 in FABP). This segmentation creates discrete, addressable labeling sites that can be targeted by site-specific chemistry. The segmentation approach allows systematic generation of probe variants with different specificities while maintaining a standardized labeling protocol, reducing overall process complexity.
Solution Approach 2:
The patent uses cysteine residues as intermediary sites for fluorophore attachment. The thiol group of cysteine serves as a chemical intermediary that enables selective covalent bonding to maleimide-containing fluorophores. This intermediary mechanism provides a reliable bridge between the protein structure and the fluorescent label, ensuring consistent labeling while simplifying the overall probe generation process through chemoselective reactions.
3Adaptability or versatility
If multiple lysine residues are present, then labeling flexibility is increased, but labeling homogeneity is reduced
Solution Approach 1:
The patent applies local quality by introducing cysteine residues at specific local positions within the protein structure (e.g., position 27 in the binding pocket). This localized modification creates a unique labeling site with distinct chemical properties compared to surface-exposed lysines. The local quality approach ensures that labeling occurs at a predetermined location with high homogeneity, while the protein retains its overall structure and function.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the rapid generation and screening of probes with improved specificity and sensitivity, reducing the need for extensive protein characterization and ensuring accurate measurement of unbound analyte concentrations, thereby enhancing the diagnostic potential for health and disease monitoring.
Implementation Method 1
cysteine-labeled fluorescent probes of unbound analytes that undergo a change in fluorescence ratio at 2 wavelengths upon binding an unbound analyte
Data Source
AI summary
A method for high throughput discovery of proteins fluorescently labeled at a cysteine residue and that undergo a change in fluorescence ratio at 2 wavelengths upon binding an unbound analyte is described. Probes are disclosed which are labeled at a cysteine residue and also probes labeled at both cysteine and lysine with two different fluorophores. These probes are useful for characterization and measurement of hydrophobic species in a fluid sample, particularly characterization and measurement of levels of unbound free fatty acids. A profile of unbound free fatty acids can be determined for an individual which can be used to determine the individual's relative risk for disease.